SINGAPORE – People who are severely immunocompromised can now receive the Covid-19 vaccine, said the Expert Committee on Covid-19 Vaccination on Wednesday (July 28).
Updating its recommendation for this group, the committee said data has shown vaccination is safe and can protect immunocompromised people – who face greater risk of complications from Covid-19 – against infection and severe disease.
In a statement, the committee also recommended that people who have recovered from Covid-19 receive one dose of a vaccine under the national vaccination programme at least three months after the date of infection.
This is sooner from the six months previously.
The Moderna and Pfizer-BioNTech/Comirnaty shots – both mRNA vaccines – are offered under the national programme.
Immunocompromised patients should obtain a memo on their suitability to receive a jab from their doctor before getting vaccinated, the committee added.
They are:
– Patients with active cancer on treatment (chemotherapy, immunotherapy or radiotherapy), who have received treatment in the last three months, or are planning to get treatment in the next two months.
– Patients who have undergone an organ or stem cell transplant within the past three months.
SINGAPORE – People who are severely immunocompromised can now receive the Covid-19 vaccine, said the Expert Committee on Covid-19 Vaccination on Wednesday (July 28).
Updating its recommendation for this group, the committee said data has shown vaccination is safe and can protect immunocompromised people – who face greater risk of complications from Covid-19 – against infection and severe disease.
In a statement, the committee also recommended that people who have recovered from Covid-19 receive one dose of a vaccine under the national vaccination programme at least three months after the date of infection.
This is sooner from the six months previously.
The Moderna and Pfizer-BioNTech/Comirnaty shots – both mRNA vaccines – are offered under the national programme.
Immunocompromised patients should obtain a memo on their suitability to receive a jab from their doctor before getting vaccinated, the committee added.
They are:
– Patients with active cancer on treatment (chemotherapy, immunotherapy or radiotherapy), who have received treatment in the last three months, or are planning to get treatment in the next two months.
– Patients who have undergone an organ or stem cell transplant within the past three months.
Array
